SuspendedNot Applicable

Prospective Observational Study and Biobank CKIO

Stopped: replaced by other study

Denmark100 participantsStarted 2020-09-01

Plain-language summary

Prospective observational study and biobank in all persons referred to CKIO * Patient involvement and quality of life * Population characteristics regarding hormone levels, safety parameters and clinical outcome before and after gender affirming hormone treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All Individuals with gender dysforia who are referred to Center of Gender Identity Odense * Age 18+ Exclusion Criteria: °There are no exclusion criteria

What they're measuring

Patient reported outcomes (PRO)

Timeframe: Every 52 weeks

Hormone levels

Timeframe: Every 52 weeks

Safety parameters

Timeframe: Every 52 weeks

Trial details

NCT IDNCT04440722

SponsorOdense University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2040-08-01

View on ClinicalTrials.gov More Transgender trials